Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Shu, Quan
Zhou, Joseph S
J. Rutherfurd, Kay
Birtles, Mervyn J
Prasad, Jaya
Gopal, Pramod K
and
Gill, Harsharnjit S
1999.
Probiotic lactic acid bacteria (Lactobacillus acidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019) have no adverse effects on the health of mice.
International Dairy Journal,
Vol. 9,
Issue. 11,
p.
831.
Zhou, J.S
Shu, Q
Rutherfurd, K.J
Prasad, J
Birtles, M.J
Gopal, P.K
and
Gill, H.S
2000.
Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice.
International Journal of Food Microbiology,
Vol. 56,
Issue. 1,
p.
87.
Zhou, J.S
Shu, Q
Rutherfurd, K.J
Prasad, J
Gopal, P.K
and
Gill, H.S
2000.
Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria.
Food and Chemical Toxicology,
Vol. 38,
Issue. 2-3,
p.
153.
Shu, Quan
Lin, Hai
Rutherfurd, Kay J.
Fenwick, Stan G.
Prasad, Jaya
Gopal, Pramod K.
and
Gill, Harsharnjit S.
2000.
Dietary Bifidobacterium lactis (HN019) Enhances Resistance to Oral Salmonella typhimurium Infection in Mice.
Microbiology and Immunology,
Vol. 44,
Issue. 4,
p.
213.
Tannock, G. W.
Munro, K.
Harmsen, H. J. M.
Welling, G. W.
Smart, J.
and
Gopal, P. K.
2000.
Analysis of the Fecal Microflora of Human Subjects Consuming a Probiotic Product Containing
Lactobacillus rhamnosus
DR20
.
Applied and Environmental Microbiology,
Vol. 66,
Issue. 6,
p.
2578.
Sheih, Ying-H.
Chiang, Bor-L.
Wang, Ling-H.
Liao, Chuh-K.
and
Gill, Harsharnjit S.
2001.
Systemic Immunity-Enhancing Effects in Healthy Subjects Following Dietary Consumption of the Lactic Acid BacteriumLactobacillus rhamnosusHN001.
Journal of the American College of Nutrition,
Vol. 20,
Issue. 2,
p.
149.
de Waard, R.
Garssen, J.
Snel, J.
Bokken, G. C. A. M.
Sako, T.
Huis in 't Veld, J. H. J.
and
Vos, J. G.
2001.
Enhanced Antigen-Specific Delayed-Type Hypersensitivity and Immunoglobulin G2b Responses after Oral Administration of ViableLactobacillus caseiYIT9029 in Wistar and Brown Norway Rats.
Clinical Diagnostic Laboratory Immunology,
Vol. 8,
Issue. 4,
p.
762.
Gopal, Pramod K
Prasad, Jaya
Smart, John
and
Gill, Harsharanjit S
2001.
In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli.
International Journal of Food Microbiology,
Vol. 67,
Issue. 3,
p.
207.
Sartor, R. Balfour
2001.
Induction of mucosal immune responses by bacteria and bacterial components.
Current Opinion in Gastroenterology,
Vol. 17,
Issue. 6,
p.
555.
Gill, Harsharnjit S
Rutherfurd, Kay J
Cross, Martin L
and
Gopal, Pramod K
2001.
Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019.
The American Journal of Clinical Nutrition,
Vol. 74,
Issue. 6,
p.
833.
Cross, M.L.
Stevenson, L.M.
and
Gill, H.S.
2001.
Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria?.
International Immunopharmacology,
Vol. 1,
Issue. 5,
p.
891.
Low, P. P. L.
Rutherfurd, K. J.
Cross, M. L.
and
Gill, H. S.
2001.
Enhancement of Mucosal Antibody Responses by Dietary Whey Protein Concentrate.
Food and Agricultural Immunology,
Vol. 13,
Issue. 4,
p.
255.
Michetti, Pierre
2001.
Lactobacilli for the management of Helicobacter pylori.
Nutrition,
Vol. 17,
Issue. 3,
p.
268.
Shu, Quan
Qu, Freeman
and
Gill, Harsharnjit S.
2001.
Probiotic Treatment Using Bifidobacterium lactis HN019 Reduces Weanling Diarrhea Associated With Rotavirus and Escherichia coli Infection in a Piglet Model.
Journal of Pediatric Gastroenterology and Nutrition,
Vol. 33,
Issue. 2,
p.
171.
Cunningham-Rundles, Susanna
2001.
Nutrition and the mucosal immune system.
Current Opinion in Gastroenterology,
Vol. 17,
Issue. 2,
p.
171.
Gill, H.S.
and
Rutherfurd, K.J.
2001.
Viability and dose–response studies on the effects of the immunoenhancing lactic acid bacteriumLactobacillus rhamnosusin mice.
British Journal of Nutrition,
Vol. 86,
Issue. 2,
p.
285.
Shu, Quan
Qu, Freeman
and
Gill, Harsharnjit S.
2001.
Probiotic Treatment Using Bifidobacterium lactis HN019 Reduces Weanling Diarrhea Associated With Rotavirus and Escherichia coli Infection in a Piglet Model.
Journal of Pediatric Gastroenterology and Nutrition,
Vol. 33,
Issue. 2,
p.
171.
Gopal, Pramod K
Sullivan, Patrick A
and
Smart, John B
2001.
Utilisation of galacto-oligosaccharides as selective substrates for growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus rhamnosus DR20.
International Dairy Journal,
Vol. 11,
Issue. 1-2,
p.
19.
Gill, Harsharnjit S
and
Rutherfurd, Kay J
2001.
Probiotic supplementation to enhance natural immunity in the elderly: effects of a newly characterized immunostimulatory strain Lactobacillus rhamnosus HN001 (DR20™) on leucocyte phagocytosis.
Nutrition Research,
Vol. 21,
Issue. 1-2,
p.
183.
Zhou, J.S.
Gopal, P.K.
and
Gill, H.S.
2001.
Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro.
International Journal of Food Microbiology,
Vol. 63,
Issue. 1-2,
p.
81.